United Spirits - How beautifully chart patterns work on a monthly scale, too. I was bullish on this for the reason that it is coming out from a very strong tight consolidation zone. https://t.co/rdjPmgFN7d
United Spirits (McDowell) - I will not wait for the monthly closing and will take an entry in this with an SL at 690. I lose almost nothing in lieu of the potential reward. https://t.co/HCnRuWvIpO pic.twitter.com/echxv0Aav0
— The_Chartist \U0001f4c8 (@nison_steve) September 2, 2021
More from The_Chartist 📈
Tata Elxsi (W) - near to the resistance zone again 5th time. @nishkumar1977 @suru27 @rohanshah619 @indian_stockss @sanstocktrader @BissaGauravB @RajarshitaS @PAVLeader @Rishikesh_ADX @VijayThk @Investor_Mohit @TrendTrader85 @jitendra_stock pic.twitter.com/aIC5kO8XqA
— Steve Nison (@nison_steve) December 18, 2020
Sir Edwards & Magee discussed sloping necklines in H&S in their classical work. I am considering this breakdown by Affle as an H&S top breakdown with a target open of 770.
— The_Chartist \U0001f4c8 (@charts_zone) May 25, 2022
The target also coincides with support at the exact same level. pic.twitter.com/n84kSgkg4q
More from Mcdowell
Holding 660 & 680, poised for big run in the days, weeks & months ahead.
Volume goes with rises
Thank you.\U0001f64f
— Van Ilango (JustNifty) (@JustNifty) August 18, 2021
A fresh input for you. #McDowell
A major triangle break out in the coming months.
Presently poised to move out of recent consolidation pic.twitter.com/J15F06ODUq
You May Also Like
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj
@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
Why is this the most powerful question you can ask when attempting to reach an agreement with another human being or organization?
A thread, co-written by @deanmbrody:
Next level tactic when closing a sale, candidate, or investment:
— Erik Torenberg (@eriktorenberg) February 27, 2018
Ask: \u201cWhat needs to be true for you to be all in?\u201d
You'll usually get an explicit answer that you might not get otherwise. It also holds them accountable once the thing they need becomes true.
2/ First, “X” could be lots of things. Examples: What would need to be true for you to
- “Feel it's in our best interest for me to be CMO"
- “Feel that we’re in a good place as a company”
- “Feel that we’re on the same page”
- “Feel that we both got what we wanted from this deal
3/ Normally, we aren’t that direct. Example from startup/VC land:
Founders leave VC meetings thinking that every VC will invest, but they rarely do.
Worse over, the founders don’t know what they need to do in order to be fundable.
4/ So why should you ask the magic Q?
To get clarity.
You want to know where you stand, and what it takes to get what you want in a way that also gets them what they want.
It also holds them (mentally) accountable once the thing they need becomes true.
5/ Staying in the context of soliciting investors, the question is “what would need to be true for you to want to invest (or partner with us on this journey, etc)?”
Multiple responses to this question are likely to deliver a positive result.